Alivus Life Sciences Limited (NSE:ALIVUS)
India · Delayed Price · Currency is INR 1,158.00
+62.30 (5.69%)
Jul 31, 2026, 3:29 PM IST
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 142.38 billion as of July 31, 2026. Its market cap has increased by 10.54% in one year.
Market Cap
142.38B
Enterprise Value
135.12B
Revenue
25.90B
Ranking
n/a
PE Ratio
23.66
Stock Price
1,158.00
ChartMarket Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 142.38B, an increase of 55.25%. That is a compound annual growth rate of 9.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 142.38B | 26.61% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
| Aug 6, 2021 | 91.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wockhardt | 318.44B |
| Piramal Pharma | 259.61B |
| Eris Lifesciences | 187.72B |
| NATCO Pharma | 164.24B |
| Cohance Lifesciences | 162.61B |
| Alembic Pharmaceuticals | 156.67B |
| Akums Drugs and Pharmaceuticals | 100.79B |
| Sudeep Pharma | 99.51B |